Royalty Pharma Plc
Biotechnology
Healthcare
RPRX
578 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
35.89
52 week high
37.91
high
36.70
52 week low
0.00
low
35.85
growth
32.70 %
previous Close
35.86
P/E ratio
34
market cap
20.17 B
div yield
0
usd
Mar 2025
qoq
revenue
568 M
-4.34 %
net incoming
238 M
14.59 %
eps
1.06 %
-7.83 %
eps surprise
11.58 %
net profit margin
41.94 %
6.00 %
operating incoming
534 M
47.56 %
net change in cash
159 M
854.75 %
cash on hand
1.09 B
17.08 %
cost of revenue
0.00 %
top top